Value of micromorphometric criteria of sentinel lymph node metastases in predicting further nonsentinel lymph node metastases in patients with melanoma

Melanoma Research

Volumn 21, Issue 2, 2011, Pages 139-143

  Fink, Astrid Maria ^a   Weihsengruber, Felix ^b   Duschek, Nikolaus ^a   Schierl, Michael ^c   Wondratsch, Hannes ^c   Jurecka, Wolfgang ^a   Rappersberger, Klemens ^b   Steiner, Andreas ^c  

^a WILHELMINEN HOSPITAL   (Austria)

^b Rudolfstiftung   (Austria)

^c Krankenhaus Hietzing   (Austria)

Author keywords

Lymphadenectomy; melanoma; microanatomic location; micromorphometric criteria; S classification; sentinel lymph node biopsy; size of sentinel node metastases

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER MORPHOLOGY; CANCER PATIENT; CANCER STAGING; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORPHOMETRICS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROBABILITY; SENTINEL LYMPH NODE; TISSUE SECTION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; YOUNG ADULT;

EID: 79952991671     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e328343ecf4     Document Type: Article

References (41)

1. Thompson JF, Shaw HM. Sentinel node mapping for melanoma: results of trials and current applications. Surg Oncol Clin N Am 2007;16:35-54. (Pubitemid 46335780)
2. Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng CH, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976-983. (Pubitemid 29109331)
3. Cascinelli N, Belli F, Santinami M, Fait V, Testori A, Ruka W, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 2000;7:469-474. (Pubitemid 30439307)
4. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel node biopsy or nodal observation in melanoma. N Engl J Med 2006;355:1307-1317. (Pubitemid 44465459)
5. McMasters KM, Wong SL, Edwards MJ, Chao C, Ross MI, Noyes RD, et al. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol 2001;19:2851-2855. (Pubitemid 32538194)
6. Van Akkooi AC, de Wilt JH, Verhoef C, Graveland WJ, Van Geel AN, Kliffen M, et al. High-positive sentinel node identification rate by EORTC melanoma group protocol: prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. Eur J Cancer 2006;42:372-380. (Pubitemid 43132893)
7. Thompson JF, McCarthy WH, Bosch CM, O'Brien CJ, Quinn MJ, Paramaesvaran S, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995;5:255-260.
8. Cascinelli N, Bombardieri E, Bufalino R, Camerini T, Carbone A, Clemente C, et al. Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival. J Clin Oncol 2006;24:4464-4471. (Pubitemid 46630985)
9. Balch CM, Morton DL, Gershenwald JE, McMasters KM, Nieweg OE, Powell B, et al. Sentinel node biopsy and standard of care for melanoma. J Am Acad Dermatol 2009;60:872-875.
10. Carlson GW, Murray DR, Lyles RH, Staley CA, Hestley A, Cohen C. The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance? Ann Surg Oncol 2003;10:575-581. (Pubitemid 40486923)
11. Reeves ME, Delgado R, Busam KJ, Brady MS, Coit DG. Prediction of nonsentinel lymph node status in melanoma. Ann Surg Oncol 2003;10:27-31.
12. Cochran AJ, Wen DR, Huang RR, Wang HJ, Elashoff R, Morton DL. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol 2004;17:747-755. (Pubitemid 38843356)
13. Lee JH, Essner R, Torisu-Itakura H, Wanek L, Wang H, Morton DL. Factors predictive of tumor-positive nonsentinel lymph nodes after tumorpositive sentinel lymph node dissection for melanoma. J Clin Oncol 2004;22:3677-3684. (Pubitemid 41095206)
14. Vuylsteke RJ, Borgstein PJ, Van Leeuwen PA, Gietema HA, Molenkamp BG, Statius Muller MG, et al. Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma. Ann Surg Oncol 2005;12:440-448. (Pubitemid 40884258)
15. Scolyer RA, Li LX, McCarthy SW, Shaw HM, Stretch JR, Sharma R, et al. Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. Am J Clin Pathol 2004;122:532-539. (Pubitemid 39281249)
16. Dewar DJ, Newell B, Green MA, Topping AP, Powell BW, Cook MG. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 2004;22:3345-3349. (Pubitemid 41103692)
17. Starz H, Balda BR, Krämer KU, Büchels H, Wang H. A micromorphometrybased concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001;91:2110-2121. (Pubitemid 32476376)
18. Frankel TL, Griffith KA, Lowe L, Wong SL, Bichakjian CK, Chang AE, et al. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma? Ann Surg Oncol 2008;15:2403-2411.
19. Rossi CR, De Salvo GL, Bonandini E, Mocellin S, Foletto M, Pasquali S, et al. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node. Ann Surg Oncol 2008;15:1202-1210.
20. Debarbieux S, Duru G, Dalle S, Béatrix O, Balme B, Thomas L. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection. Br J Dermatol 2007;157:58-67. (Pubitemid 46934258)
21. Page AJ, Carlson GW, Delman KA, Murray D, Hestley A, Cohen C. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma. Am Surg 2007;73:674-678. (Pubitemid 351396619)
22. Scheri RP, Essner R, Turner RR, Ye X, Morton DL. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Ann Surg Oncol 2007;14:2861-2866. (Pubitemid 47460638)
23. Fink AM, Weihsengruber F, Spangl B, Feichtinger H, Lilgenau N, Rappersberger K, et al. S-classification of sentinel lymph node biopsy predicts the results of complete regional lymph node dissection. Melanoma Res 2005;15:267-271. (Pubitemid 41127462)
24. Starz H, Siedlecki K, Balda BR. Sentinel lymphonodectomy and S-classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol 2004;11:162S-168S.
25. Ollila DW, Ashburn JH, Amos KD, Yeh JJ, Frank JS, Deal AM, et al. Metastatic melanoma cells in the sentinel node cannot be ignored. J Am Coll Surg 2009;208:924-929.
26. Younan R, Bougrine A, Watters K, Mahboubi A, Bouchereau-Eyegue M, Loutfi A, et al. Validation study of the S-classification for melanoma patients with positive sentinel nodes: the Montreal experience. Ann Surg Oncol 2010;17:1414-1421.
27. Wright EH, Stanley PR, Roy A. Evaluation of sentinel lymph nodes positive for melanoma for features predictive of non-sentinel nodal disease and patient prognosis: a 49 patient series. J Plast Reconstr Aesthet Surg 2010;63:500-502.
28. Satzger I, Völker B, Meier A, Kapp A, Gutzmer R. Criteria in sentinel lymph nodes of melanoma patients that predict involvement of nonsentinel lymph nodes. Ann Surg Oncol 2008;15:1723-1732.
29. Starz H, Cochran AJ, Balda BR. Histopathological aspects of the sentinel lymphonodectomy (German). Aktuelle Dermatologie 2002;28:273-278.
30. Satzger I, Völker B, Al Ghazal M, Meier A, Kapp A, Gutzmer R. Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology 2007;50:764-772. (Pubitemid 46683934)
31. Roka F, Mastan P, Binder M, Okamoto I, Mittlboeck M, Horvat R, et al. Prediction of non-sentinel node status and outcome in sentinel nodepositive melanoma patients. Eur J Surg Oncol 2008;34:82-88. (Pubitemid 350296755)
32. Van Akkooi AC, Nowecki ZI, Voit C, Schäfer-Hesterberg G, Michej W, de Wilt JH, et al. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes. Ann Surg 2008;248:949-955.
33. Fink AM, Holle-Robatsch S, Herzog N, Mirzaei S, Rappersberger K, Lilgenau N, et al. Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II. Melanoma Res 2004;14:141-145. (Pubitemid 38535095)
34. Cook MG, Green MA, Anderson B, Eggermont AM, Ruiter DJ, Spatz A, et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 2003;200:314-319. (Pubitemid 36827305)
35. Van Akkooi AC, Voit CA, Verhoef C, Eggermont AM. New developments in sentinel node staging in melanoma: controversies and alternatives. Curr Opin Oncol 2010;22:169-177.
36. Van Akkooi AC, de Wilt JH, Verhoef C, Schmitz PI, Van Geel AN, Eggermont AM, et al. Clinical relevance of melanoma micrometastases (0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol 2006;17:1578-1585. (Pubitemid 44542045)
37. Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W. Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes: one institution's experience. Melanoma Res 2003;13:35-43. (Pubitemid 36269812)
38. Statius Muller MG, Borgstein PJ, Pijpers R, Van Leeuwen PA, Van Diest PJ, Gupta A, et al. Reliability of the sentinel node procedure in melanoma patients: analysis of failures after long-term follow-up. Ann Surg Oncol 2000;7:461-468. (Pubitemid 30439306)
39. Tsutsumida A, Furukawa H, Hata S, Saito A, Yamamoto Y. Prediction of metastases in melanoma patients with positive sentinel node: histological and molecular approach. J Dermatol 2007;34:31-36. (Pubitemid 46005954)
40. Murali R, Cochran AJ, Cook MG, Hillman JD, Karim RZ, Moncrieff M, et al. Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma. Cancer 2009;115:5026-5037.
41. Riber-Hansen R, Nyengaard JR, Hamilton-Dutoit SJ, Steiniche T. Stage migration after minor changes in histologic estimation of tumor burden in sentinel lymph nodes: the protocol trap. Cancer 2009;115:2177-2187.